NFKB1 and cystic fibrosis: Despite the well-documented involvement of NF-κB activation in CF-related inflammations and well-demonstrated inverse relationship between CFTR and NF-κB activation in different experimental settings [37–41], the solid evidence linking CFTR mutation to aberrant NF-κB activation remains mysteriously missing.